Literature DB >> 4190967

Complement-requiring neutralizing antibodies in Herpesvirus hominis encephalitis.

A M Lerner, E J Bailey, D C Nolan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4190967

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  8 in total

1.  Approach to diagnosis and treatment of herpes simplex encephalitis. A report of two cases.

Authors:  M J Gurwith; C E Harman; T C Merigan
Journal:  Calif Med       Date:  1971-12

2.  Heat-labile accessory factor involved in vaccinia virus plaque neutralization.

Authors:  T C O'Brien; J E Hannah; N M Tauraso
Journal:  Arch Gesamte Virusforsch       Date:  1973

3.  Neurological infections caused by herpes simplex virus in adults.

Authors:  A Ferencz; L Binder; F Kovács; G Káli; A Pálfi; I Hollós
Journal:  Infection       Date:  1978       Impact factor: 3.553

4.  Effect of staphylococcal protein A on complement-potentiated neutralization of herpes simplex virus and immune lysis of virus-infected cells.

Authors:  R M Austin; C A Daniels
Journal:  Infect Immun       Date:  1975-10       Impact factor: 3.441

5.  Neutralizing antibody responses to varicella-zoster virus.

Authors:  N J Schmidt; E H Lennette
Journal:  Infect Immun       Date:  1975-09       Impact factor: 3.441

6.  Assessment of cytosine arabinoside as an antiviral agent in humans.

Authors:  C B Lauter; E J Bailey; A M Lerner
Journal:  Antimicrob Agents Chemother       Date:  1974-11       Impact factor: 5.191

7.  Type specificity of complement-requiring and immunoglobulin M neutralizing antibody in initial herpes simplex virus infections of humans.

Authors:  N J Schmidt; B Forghani; E H Lennette
Journal:  Infect Immun       Date:  1975-10       Impact factor: 3.441

8.  Concentrations of idoxuridine in serum, urine, and cerebrospinal fluid of patients with suspected diagnoses of Herpesvirus hominis encephalitis.

Authors:  A M Lerner; E J Bailey
Journal:  J Clin Invest       Date:  1972-01       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.